🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open ended study in which patients who completed the double-blind study ...
Status
Completed
Location
152
Start Date
2005-06
Trial ID
NCT00175877
Treatments Being Tested
Phase 4 study to evaluate a routine patient completed assessment (RAPID3) c...
Status
Completed
Location
137
Start Date
2010-11
Trial ID
NCT01255761
Treatments Being Tested
The aim of the study will be to investigate the effect of certolizumab pego...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00297648
Treatments Being Tested
This study is conducted to evaluate the short (12 Weeks) and long term (104...
Status
Completed
Location
141
Start Date
2011-12
Trial ID
NCT01500278
Treatments Being Tested
This study will characterize the pharmacokinetics (PK) of certolizumab pego...
Status
Completed
Location
1
Start Date
2015-03
Trial ID
NCT02365948
Treatments Being Tested
The primary objective is to assess differences in PASI scores between Week ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00329303
Treatments Being Tested
Hypothesis: Cimzia provides superior reduction in endoscopic and clinical r...
Status
Terminated
Location
Penn State Milton S. Hershey Medical Center
Start Date
2013-02
Trial ID
NCT01696942
Treatments Being Tested
The study will continue to assess the safety of certolizumab pegol (CDP870)...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00333788
Treatments Being Tested
To assess the clinical efficacy of subcutaneous (sc) certolizumab pegol adm...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00308581
Treatments Being Tested
The current study is designed to measure the corticosteroid-sparing effect ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00349752
Treatments Being Tested